James Bristol's most recent trade in Erasca Inc was a trade of 37,762 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 37,762 | 37,762 | - | - | Stock Option (right to buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 120,000 | 120,000 | - | - | Stock option (right to buy) | |
| Eterna Therapeutics Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 72,074 | 72,074 | - | - | Stock Option (Right to buy) | |
| Erasca Inc | James Bristol A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 45,678 | 45,678 | - | - | Stock Option (right to buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Eterna Therapeutics Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 124,525 | 124,525 | - | - | Stock Option (Right to buy) | |
| Erasca Inc | James Bristol A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,747 | 62,747 | - | - | Stock Option (right to buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | James A. Bristol | Director | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 21 Dec 2022 | 20,000 | 20,000 | - | 4.1 | 82,800 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 9,570 | 9,570 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 5,300 | 23,850 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 19 Apr 2021 | 5,300 | 5,300 (0%) | 0% | 4.0 | 20,935 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Sale of securities on an exchange or to another person at price $ 46.13 per share. | 19 Apr 2021 | 4,000 | 1,300 (0%) | 0% | 46.1 | 184,518 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 1,700 | 22,150 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Sale of securities on an exchange or to another person at price $ 45.60 per share. | 19 Apr 2021 | 1,700 | 0 (0%) | 0% | 45.6 | 77,514 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 19 Apr 2021 | 1,700 | 1,700 (0%) | 0% | 4.0 | 6,715 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Sale of securities on an exchange or to another person at price $ 46.66 per share. | 19 Apr 2021 | 1,300 | 0 (0%) | 0% | 46.7 | 60,662 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 14,700 | 29,150 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 12 Apr 2021 | 14,700 | 14,700 (0%) | 0% | 4.0 | 58,065 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Sale of securities on an exchange or to another person at price $ 43.70 per share. | 12 Apr 2021 | 9,483 | 5,217 (0%) | 0% | 43.7 | 414,370 | Common Stock |
| Deciphera Pharmaceuticals Inc | James Bristol | Director | Sale of securities on an exchange or to another person at price $ 44.09 per share. | 12 Apr 2021 | 5,217 | 0 (0%) | 0% | 44.1 | 230,040 | Common Stock |